Variant report
Variant | nsv521480 |
---|---|
Chromosome Location | chr4:81941456-81943068 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:81942639..81943385-chr7:30269373..30270144,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6814223 | chr4:81941456-81941457 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs138857930 | chr4:81941458-81941459 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs374848231 | chr4:81941472-81941473 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs79771569 | chr4:81941527-81941528 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs17005020 | chr4:81941528-81941529 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
6 | rs559594830 | chr4:81941554-81941555 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs549204594 | chr4:81941578-81941579 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs528313882 | chr4:81941619-81941620 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs550708728 | chr4:81941632-81941633 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs200593422 | chr4:81941668-81941669 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs567704722 | chr4:81941680-81941681 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs371771549 | chr4:81941692-81941693 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs564427181 | chr4:81941695-81941696 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs375716850 | chr4:81941697-81941698 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs145642897 | chr4:81941733-81941734 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs549778412 | chr4:81941741-81941742 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs569752617 | chr4:81941758-81941759 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs371197753 | chr4:81941761-81941762 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs529230099 | chr4:81941770-81941771 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs73831255 | chr4:81941841-81941842 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs566355148 | chr4:81941895-81941896 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs534906716 | chr4:81941896-81941897 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs546981259 | chr4:81941932-81941933 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs555421834 | chr4:81942048-81942049 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs572144581 | chr4:81942053-81942054 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs558300690 | chr4:81942110-81942111 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs534817020 | chr4:81942120-81942121 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs75882173 | chr4:81942135-81942136 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs557071253 | chr4:81942196-81942197 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs573725708 | chr4:81942210-81942211 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs141983066 | chr4:81942218-81942219 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs370228944 | chr4:81942244-81942245 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs143334402 | chr4:81942254-81942255 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs58129258 | chr4:81942261-81942262 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs578162848 | chr4:81942295-81942296 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs181013870 | chr4:81942308-81942309 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs184994329 | chr4:81942334-81942335 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs59021208 | chr4:81942406-81942407 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs188680193 | chr4:81942438-81942439 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs557501329 | chr4:81942496-81942497 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs77646366 | chr4:81942526-81942527 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs58713718 | chr4:81942547-81942548 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs529291203 | chr4:81942602-81942603 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs542778079 | chr4:81942641-81942642 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs146299320 | chr4:81942669-81942670 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs559480958 | chr4:81942674-81942675 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs79478926 | chr4:81942676-81942677 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs551769141 | chr4:81942739-81942740 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs181242643 | chr4:81942740-81942741 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs72868561 | chr4:81942838-81942839 | Enhancers Weak transcription Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Gastric cancer | 16891809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 22522925 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:81939800-81942000 | Enhancers | Rectal Mucosa Donor 29 | rectum |
2 | chr4:81939800-81943000 | Enhancers | Rectal Mucosa Donor 31 | rectum |
3 | chr4:81940000-81944200 | Enhancers | Fetal Intestine Large | intestine |
4 | chr4:81940800-81944200 | Enhancers | Fetal Intestine Small | intestine |
5 | chr4:81941000-81942400 | Enhancers | Small Intestine | intestine |
6 | chr4:81941400-81941600 | Enhancers | H9 Cell Line | embryonic stem cell |
7 | chr4:81941400-81941800 | Enhancers | Duodenum Mucosa | Duodenum |
8 | chr4:81941400-81942200 | Enhancers | Sigmoid Colon | Sigmoid Colon |
9 | chr4:81941800-81943200 | Weak transcription | Duodenum Mucosa | Duodenum |
10 | chr4:81942000-81942600 | Flanking Active TSS | Rectal Mucosa Donor 29 | rectum |
11 | chr4:81942600-81942800 | Enhancers | Fetal Lung | lung |
12 | chr4:81942600-81943200 | Active TSS | Rectal Mucosa Donor 29 | rectum |
13 | chr4:81942600-81943200 | Active TSS | Stomach Smooth Muscle | stomach |
14 | chr4:81942600-81943800 | Enhancers | Duodenum Smooth Muscle | Duodenum |
15 | chr4:81942800-81943400 | Enhancers | Rectal Smooth Muscle | rectum |
16 | chr4:81942800-81943600 | Enhancers | Stomach Mucosa | stomach |
17 | chr4:81942800-81944000 | Enhancers | Colon Smooth Muscle | Colon |
18 | chr4:81943000-81943600 | Flanking Active TSS | Rectal Mucosa Donor 31 | rectum |